BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7529078)

  • 1. Detection of trisomy 12 by FISH in untreated B-chronic lymphocytic leukemia: correlation with stage and CD20 antigen expression intensity.
    Witzig TE; Borell TJ; Herath JF; Tefferi A; Li CY; Jenkins RB
    Leuk Lymphoma; 1994 Aug; 14(5-6):447-51. PubMed ID: 7529078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescent in situ hybridization and cytogenetic studies of trisomy 12 in chronic lymphocytic leukemia.
    Escudier SM; Pereira-Leahy JM; Drach JW; Weier HU; Goodacre AM; Cork MA; Trujillo JM; Keating MJ; Andreeff M
    Blood; 1993 May; 81(10):2702-7. PubMed ID: 7683927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
    Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
    Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trisomy 12 in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: analysis by stage, immunophenotype, and morphology.
    Que TH; Marco JG; Ellis J; Matutes E; Babapulle VB; Boyle S; Catovsky D
    Blood; 1993 Jul; 82(2):571-5. PubMed ID: 7687164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trisomy 12 in chronic lymphocytic leukemia and hairy cell leukemia: a cytogenetic and interphase cytogenetic study.
    Cuneo A; Bigoni R; Balboni M; Carli MG; Piva N; Fagioli F; Latorraca A; Wlodarska I; van den Berghe H; Castoldi G
    Leuk Lymphoma; 1994 Sep; 15(1-2):167-72. PubMed ID: 7858495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
    Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
    Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, biological, and immunophenotypical characteristics of B-cell chronic lymphocytic leukemia with trisomy 12 by fluorescence in situ hybridization.
    Tabernero MD; San Miguel JF; Garcia JL; Garcia-Isidoro M; Wiegant J; Ciudad J; Gonzalez M; Rios A; Raap A; Orfao A
    Cytometry; 1995 Sep; 22(3):217-22. PubMed ID: 8556953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trisomy 12 in chronic lymphocytic leukemia. An interphase cytogenetic study by fluorescence in situ hybridization.
    Kwong YL; Pang J; Ching LM; Liu HW; Liang RH; Chan LC
    Cancer Genet Cytogenet; 1994 Feb; 72(2):83-5. PubMed ID: 8143280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trisomy 12 in B-cell chronic lymphocytic leukemia: interphase study by in situ hybridization in 75 patients.
    Coignet L; Berthéas MF; Vasselon C; Jaubert J; Reynaud J; Calmard-Oriol P; Brizard CP; Guyotat D
    Nouv Rev Fr Hematol (1978); 1993 Apr; 35(2):129-34. PubMed ID: 8332448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trisomy 12 and p53 deletion in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: association with morphology and resistance to conventional chemotherapy.
    Cano I; Martinez J; Quevedo E; Pinilla J; Martin-Recio A; Rodriguez A; Castañeda A; López R; Pérez-Piño T; Hernández-Navarro F
    Cancer Genet Cytogenet; 1996 Sep; 90(2):118-24. PubMed ID: 8830719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia.
    Almasri NM; Duque RE; Iturraspe J; Everett E; Braylan RC
    Am J Hematol; 1992 Aug; 40(4):259-63. PubMed ID: 1380203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Aoun P; Blair HE; Smith LM; Dave BJ; Lynch J; Weisenburger DD; Pavletic SZ; Sanger WG
    Leuk Lymphoma; 2004 Aug; 45(8):1595-603. PubMed ID: 15370211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface antigen expression in chronic lymphocytic leukemia: clustering analysis, interrelationships and effects of chromosomal abnormalities.
    Hulkkonen J; Vilpo L; Hurme M; Vilpo J
    Leukemia; 2002 Feb; 16(2):178-85. PubMed ID: 11840283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of trisomy 12 with proliferating cells by combined immunocytochemistry and fluorescence in situ hybridization in chronic lymphocytic leukemia.
    Garcìa-Marco JA; Price CM; Ellis J; Morey M; Matutes E; Lens D; Colman S; Catovsky D
    Leukemia; 1996 Nov; 10(11):1705-11. PubMed ID: 8892671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of trisomy 12 and centromeric alterations in CLL by interphase- and metaphase-FISH.
    Acar H; Connor MJ
    Cancer Genet Cytogenet; 1998 Jan; 100(2):148-51. PubMed ID: 9428359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interphase detection of trisomy 12 in B-cell chronic lymphocytic leukemia by fluorescence hybridization in situ.
    Qumsiyeh MB; Tharapel SA
    Leukemia; 1992 Jun; 6(6):602-5. PubMed ID: 1602799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Karyotype correlates with peripheral blood morphology and immunophenotype in chronic lymphocytic leukemia.
    Finn WG; Thangavelu M; Yelavarthi KK; Goolsby CL; Tallman MS; Traynor A; Peterson LC
    Am J Clin Pathol; 1996 Apr; 105(4):458-67. PubMed ID: 8604688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mosaicism of trisomy 12 in chronic lymphocytic leukemia detected by non-radioactive in situ hybridization.
    Raghoebier S; Kibbelaar RE; Kleiverda JK; Kluin-Nelemans JC; van Krieken JH; Kok F; Kluin PM
    Leukemia; 1992 Nov; 6(11):1220-6. PubMed ID: 1434807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients.
    Matutes E; Oscier D; Garcia-Marco J; Ellis J; Copplestone A; Gillingham R; Hamblin T; Lens D; Swansbury GJ; Catovsky D
    Br J Haematol; 1996 Feb; 92(2):382-8. PubMed ID: 8603004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal B cell compartment in chronic lymphatic leukemia.
    Pluta A; Górski A; Nowaczyk M; Modlińska M
    Hematol Oncol; 1990; 8(3):121-4. PubMed ID: 1695606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.